The FDA has approved Pfizer's biosimilar version of Roche's Avastin for five oncology indications, Pfizer said. The drug is called Zirabev.
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.